According to CBS News, The Generic Pharmaceutical Association, a trade group for generic drugmakers, moved quickly to defend the track record of both the FDA and its companies.
Last year drug giant Eli Lilly enlisted the National Association of Boards of Pharmacy to take a look at Web sites that purported to sell "generic" versions of Lilly drugs.